Skip to content
healthcare.dev

ALTUVIIIO

NDC 71104-981, Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl, kit, from Bioverativ Therapeutics Inc..

Product NDC
71104-981
Status
Listed
Labeler
Bioverativ Therapeutics Inc.
Dosage form
KIT
Route
—
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125771
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71104-981 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

None listed.

Package NDCNDC-11Package
71104-981-01711040981011 KIT in 1 KIT (71104-981-01) * 3 mL in 1 VIAL (71104-988-08) * 3 mL in 1 SYRINGE (71104-035-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/01411972-df40-4ccf-88f0-d3220e5abda9
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=71104-981

Use it

Look up 71104-981 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71104-981 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71104-981. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.